SOPHiA GENETICS (NASDAQ:SOPH – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the ...

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to transform patient care by expanding access to data-driven medicine globally. It is the creator of the ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IMPACT® powered with SOPHiA DDM™ today from the ...

1 Day SOPH -0.28% DJIA 0.38% Russell 2K 1.07% Technology -1.48% ...

SOPHiA GENETICS. "Following the successful launch of MSK-ACCESS ® powered with SOPHiA DDM™ earlier this year, we are incredibly excited to further build on our excellent collaboration with MSK.

SOPHiA GENETICS (Nasdaq: SOPH ... It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad ...

This innovation underscores SOPHiA GENETICS' commitment to advancing data ... The OncoPortal™ Mutation Tracker augments the SOPHiA DDM™ Platform's core analytical capabilities to allow ...

This innovation underscores SOPHiA GENETICS' commitment to advancing data-driven approaches ... The OncoPortal™ Mutation Tracker augments the SOPHiA DDM™ Platform's core analytical capabilities to ...